Psilocybin in the treatment of end-of-life anxiety

Can psychedelics help patients cope with the fear of death?

Dr. Grob will come all the way from Los Angeles to give a lecture on his research into psilocybin, the active ingredient in 'magic mushrooms'. The main focus of this lecture will be the investigation into the safety and efficacy of psilocybin as a therapeutic aid in the treatment of severe anxiety in adult patients with advanced-stage cancer. Research into substances such as MDMA and ayahuasca, also investigated at the Harbor-UCLA Medical Center, will be addressed as well. There will be ample time for questions and discussion. Students, health care professionals and therapists are encouraged to attend.

Dr. Charles Grob is professor in Psychiatry & Biobehavioral Sciences at UCLA, Los Angeles (USA). He has published extensively on topics such as substance misuse and the history of hallucinogens in psychiatry. He performed the first FDA approved study of the physiological and psychological effects of MDMA; a multi-national study of ayahuasca in Brazil and has performed a pilot investigation of the safety and efficacy of psilocybin in the treatment of anxiety in adult patients with advanced-stage cancer.

WHO: Dr. Charles Grob (UCLA)

WHEN: Friday 14 June

TIME: 16:00 - 18:00

WHERE: CREA (Muziekzaal), Nieuwe Achtergracht 170 Amsterdam.

FEE: €5,- regular / students & alumni free

Dr. Grob is the man I'm going to college to become. His work safely and responsibly studying psychedelics in a scientific context is going to go down in history as one of the greatest scientific efforts of all time. I am convinced of it.